What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used as part of a medically supervised plan for chronic weight management and metabolic support.

At Vita Bella, licensed providers evaluate your labs, history, and goals before recommending whether semaglutide (or another therapy) is appropriate for you.

How GLP-1 medications work

GLP-1 medications act on receptors involved in appetite regulation, satiety signaling, gastric emptying, and glucose metabolism.

Many patients notice reduced hunger, earlier fullness, and improved control around food — especially when paired with nutrition and resistance training.

Benefits

Potential benefits of clinician-guided semaglutide therapy can include meaningful weight reduction, improved appetite control, and support for metabolic markers when lifestyle foundations are in place.

Your provider will discuss expected timelines, monitoring, and how to measure progress beyond the scale.

Candidate assessment

Eligibility depends on BMI, medical history, current medications, and treatment goals. Some conditions or medications may make GLP-1 therapy inappropriate.

A consultation and required labs help determine whether semaglutide, tirzepatide, or another path is the better fit.

Medical evaluation

Typical evaluation includes intake history, vitals, and laboratory review so your provider can assess safety and establish a baseline.

Follow-up check-ins help adjust dosing, manage side effects, and protect muscle and metabolic health over time.

Dosing

Semaglutide is commonly started at a low dose and increased gradually based on tolerance and clinical response.

Your prescription and titration schedule are individualized. Always follow the instructions in your portal and from your care team.

Injection instructions

Semaglutide is typically administered as a subcutaneous injection. Common sites include the abdomen, thigh, or upper arm (with assistance when needed).

Use a clean technique, rotate sites, and dispose of sharps safely. Pair this section with Vita Bella’s official subcutaneous injection resources.

Nutrition

Prioritize protein, fiber, hydration, and nutrient-dense meals to support satiety and lean mass while calories decrease.

Many patients do better with smaller, more frequent meals and slower eating as gastric emptying changes.

Exercise

Resistance training 2–4 times per week helps preserve muscle during weight loss. Add walking or other low-impact cardio as tolerated.

Progress gradually and communicate dizziness, fatigue, or joint discomfort to your care team.

Side effects

Common side effects can include nausea, constipation, diarrhea, reflux, and reduced appetite — especially during dose increases.

Strategies such as slower titration, smaller meals, and hydration often help. Persistent or severe symptoms should be reported promptly.

Safety warnings

Discuss personal and family history of medullary thyroid carcinoma, MEN2, pancreatitis, gallbladder disease, and pregnancy plans with your provider.

GLP-1 therapy is not appropriate for everyone. Your clinician will review contraindications and monitoring needs before prescribing.

Clinical studies

Semaglutide for chronic weight management has been studied in large Phase 3 programs (STEP) and in a major cardiovascular outcomes trial (SELECT).

Trial results describe average outcomes in carefully selected research populations. Your results will depend on dose, adherence, lifestyle support, medical history, and ongoing clinician guidance.

Weight-Loss Efficacy (68 Weeks)

In 1,961 adults with overweight or obesity (without diabetes), once-weekly semaglutide 2.4 mg plus lifestyle counseling produced a mean body-weight change of −14.9% at week 68 versus −2.4% with placebo (treatment difference −12.4 percentage points). About 86% lost ≥5%, 69% lost ≥10%, and 51% lost ≥15% of baseline weight on semaglutide. Cardiometabolic risk markers and self-reported physical function also improved more than with placebo. Gastrointestinal side effects (often nausea or diarrhea) were the most common adverse events and were usually mild to moderate.

Wilding et al., N Engl J Med. 2021 (STEP 1)

Cardiovascular Outcomes

In adults with preexisting cardiovascular disease plus overweight or obesity (without diabetes), once-weekly semaglutide 2.4 mg reduced major adverse cardiovascular events (cardiovascular death, nonfatal heart attack, or nonfatal stroke) versus placebo over a mean follow-up of about 40 months — roughly a 20% relative risk reduction in the primary composite endpoint. Patient takeaway: for people with established heart disease and excess weight, evidence supports benefit beyond the scale when therapy is medically supervised.

Lincoff et al., N Engl J Med. 2023 (SELECT)

What This Means For Patients

Landmark trials support clinically meaningful average weight loss with lifestyle support, and—when heart disease is already present—a reduction in serious cardiovascular events at the 2.4 mg weekly dose studied. Individual response, tolerability, and the right dose for you are decided with your Vita Bella provider; FDA labeling and contraindications still guide who should or should not use therapy.

FDA Wegovy (semaglutide) prescribing information

Long-term maintenance

Sustainable results usually require ongoing nutrition habits, strength training, sleep, and clinician follow-up — not medication alone.

Your provider may adjust dose, pause titration, or transition strategies based on progress and tolerance.

FAQs

How quickly will I see results on semaglutide?

Timelines vary. Some patients notice appetite changes within the first weeks, while meaningful body-composition changes often build over months with consistent lifestyle support.

Do I still need diet and exercise?

Yes. Medication can make adherence easier, but protein intake, resistance training, and recovery habits strongly influence quality of results.

Can I drink alcohol while taking semaglutide?

Ask your provider. Alcohol may worsen nausea or affect blood sugar and calories. Individual guidance depends on your history and goals.

What if side effects are hard to tolerate?

Message your care team. They may slow titration, adjust supportive strategies, or consider an alternative therapy.

EDUCATION CENTER